Onconetix, Inc. - Common Stock (ONCO)
0.3057
+0.00 (0.00%)
NASDAQ· Last Trade: May 19th, 9:27 AM EDT
Detailed Quote
| Previous Close | 0.3057 |
|---|---|
| Open | - |
| Bid | 0.1873 |
| Ask | 0.1889 |
| Day's Range | N/A - N/A |
| 52 Week Range | 0.3057 - 42.08 |
| Volume | 69,421,135 |
| Market Cap | 6.78M |
| PE Ratio (TTM) | 0.0001 |
| EPS (TTM) | 3,049.1 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 7,074,197 |
Chart
About Onconetix, Inc. - Common Stock (ONCO)
Onconetix Inc is a biotechnology company focused on advancing cancer diagnostics and therapeutics. The company leverages cutting-edge research and technology to develop innovative solutions aimed at improving patient outcomes in oncology. By harnessing the power of molecular biology and genomics, Onconetix aims to enhance the ability to detect and characterize tumors, enabling more effective treatment strategies tailored to individual patients. The company's commitment to precision medicine drives its ongoing efforts to contribute to the evolving landscape of cancer care through scientific discovery and collaboration. Read More
News & Press Releases
CINCINNATI, Ohio, May 19, 2026 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for oncology, today announced that its Board of Directors (the “Board of Directors” or “Board”) has approved a 1-for-10 reverse stock split of its outstanding shares of common stock, to be effective as of 12:01 a.m. Eastern Time on May 21, 2026.
By Onconetix, Inc. · Via GlobeNewswire · May 19, 2026
Stay updated with the stocks that are on the move in today's after-hours session.chartmill.com
Via Chartmill · May 18, 2026
Veru (VERU) Q2 2026 Earnings Transcript
Via The Motley Fool · May 13, 2026
New Clinical Data Reinforce Proclarix® Performance in Reducing Overdiagnosis and Unnecessary Biopsies; Multi-Center PRIME Study Initiated in Collaboration with Labcorp; European Commercial Expansion Advances
By Onconetix, Inc. · Via GlobeNewswire · May 13, 2026
These stocks are moving in today's sessionchartmill.com
Via Chartmill · April 27, 2026
Top stock movements in today's session.chartmill.com
Via Chartmill · April 27, 2026
Top movers in Monday's pre-market sessionchartmill.com
Via Chartmill · April 27, 2026
Here are the top movers in Monday's session, showcasing the stocks with significant price changes.
Via Chartmill · April 13, 2026
Stay updated with the stocks that are on the move in today's after-hours session.chartmill.com
Via Chartmill · April 9, 2026
Check out the stocks that are attracting the most attention and driving market activity.chartmill.com
Via Chartmill · April 9, 2026
Which stocks are experiencing notable movement on Thursday?chartmill.com
Via Chartmill · April 9, 2026
There are notable gap-ups and gap-downs in today's session.chartmill.com
Via Chartmill · April 9, 2026
Vinci Enables Realbotix Robots to Recognize People, Recall Conversations, and Track Engagement; Onconetix Recently Entered into a Definitive Agreement to Acquire Realbotix LLC, a Subsidiary of Realbotix Corp.
By Onconetix, Inc. · Via GlobeNewswire · April 9, 2026
Realbotix Announces Expected Delivery of 19 Robots in March, April, and May 2026 as it Scales Production Capacity; Onconetix recently Entered into a Definitive Agreement to Acquire Realbotix LLC, a subsidiary of Realbotix Corp.
By Onconetix, Inc. · Via GlobeNewswire · April 2, 2026
Wondering what's happening in today's after-hours session?chartmill.com
Via Chartmill · April 1, 2026
Experienced Leadership Team Positioned to Execute Pending Transformative Acquisition of Realbotix LLC and Drive Long-Term Shareholder Value
By Onconetix, Inc. · Via GlobeNewswire · March 31, 2026
Traders are paying attention to the gapping stocks in Monday's session.chartmill.com
Via Chartmill · March 30, 2026
Wondering what's happening in today's pre-market session?chartmill.com
Via Chartmill · March 30, 2026
Top stock movements in today's session.chartmill.com
Via Chartmill · March 27, 2026
Most active stocks in Friday's sessionchartmill.com
Via Chartmill · March 27, 2026
What's going on in today's pre-market sessionchartmill.com
Via Chartmill · March 27, 2026
Realbotix Humanoid Robot — Ericsson’s First Enterprise Robotics Client — Featured as Live Connected Endpoint in Pre-Standard 6G Over-the-Air Trial at Ericsson’s U.S. Headquarters; Onconetix Has Entered into a Definitive Agreement to Acquire Realbotix
By Onconetix, Inc. · Via GlobeNewswire · March 25, 2026
CINCINNATI, Ohio, March 23, 2026 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men’s health and oncology, today announced that its Board of Directors (the “Board of Directors” or “Board”) has approved a 1-for-5 reverse stock split of its outstanding shares of common stock, to be effective as of 12:01 a.m. Eastern Time on March 25, 2026.
By Onconetix, Inc. · Via GlobeNewswire · March 23, 2026
What's going on in today's after hours sessionchartmill.com
Via Chartmill · March 20, 2026